A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36

J. S. Andersen, A. M. Pralea, E. A. DelBono, J. L. Haines, M. B. Gorin, J. S. Schuman, C. G. Mattox and J. L. Wiggs
Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Mass, USA.

OBJECTIVES: To demonstrate the inheritance of the pigment dispersion syndrome in 4 families and to determine the location of a gene responsible for this syndrome. PATIENTS: Fifty-four members of 4 families affected by the pigment dispersion syndrome and pigmentary glaucoma. All 4 families are white. Two of the pedigrees are of Irish descent, and 2 are of mixed western European descent that includes some Irish ancestry. INTERVENTIONS: Individuals from 4 pedigrees affected by the pigment dispersion syndrome and their spouses were clinically examined for evidence of the pigment dispersion syndrome. DNA samples from patients and appropriate family members were used for a genome screen using microsatellite repeat markers distributed throughout the human genome. Genotypes were used for linkage analysis to identify markers segregating with the disease trait. RESULTS: Twenty-eight patients showed clinical evidence of the pigment dispersion syndrome. Of these, 14 also had elevated intraocular pressures requiring medical or surgical treatment or both. Significant linkage was observed between the disease phenotype and markers located on the telomere of the long arm of human chromosome 7 (i.e., 7q35-q36). The maximum 2-point lod score (i.e., Zmax) for a single pedigree (i.e., PDS5) was 5.72 at theta = 0 for markers D7S2546 and D7S550. An analysis of affected recombinant individuals demonstrated that the responsible gene is located in a 10-centimorgan interval between markers D7S2462 and D7S2423. CONCLUSIONS: The pigment dispersion syndrome was found to be inherited as an autosomal dominant trait in 4 affected pedigrees. The gene responsible for the syndrome in these 4 families maps to the telomeric end of the long arm of chromosome 7 (i.e., 7q35-q36). Locating a gene responsible for this condition is the first step toward the isolation of the gene itself. Characterization of the responsible gene will help elucidate the pathophysiology of this disease and potentially will lead to new methods of diagnosis and treatment.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genetic Etiologies of Glaucoma
Wiggs
Arch Ophthalmol 2007;125:30-37.
ABSTRACT | FULL TEXT  

Late-Onset Macular Degeneration and Long Anterior Lens Zonules Result from a CTRP5 Gene Mutation
Ayyagari et al.
IOVS 2005;46:3363-3371.
ABSTRACT | FULL TEXT  

Mutations in the Myocilin Gene in Families With Primary Open-angle Glaucoma and Juvenile Open-angle Glaucoma
Bruttini et al.
Arch Ophthalmol 2003;121:1034-1038.
ABSTRACT | FULL TEXT  

By Altering Ocular Immune Privilege, Bone Marrow-derived Cells Pathogenically Contribute to DBA/2J Pigmentary Glaucoma
Mo et al.
J. Exp. Med. 2003;197:1335-1344.
ABSTRACT | FULL TEXT  

Gene Therapy for Glaucoma: Treating a Multifaceted, Chronic Disease
Borras et al.
IOVS 2002;43:2513-2518.
FULL TEXT  

Phenylthiocarbamide Taste Testing in Patients With Pigmentary Glaucoma
Ritch et al.
Arch Ophthalmol 2001;119:309-310.
FULL TEXT  

GLC1F, A New Primary Open-angle Glaucoma Locus, Maps to 7q35-q36
Wirtz et al.
Arch Ophthalmol 1999;117:237-241.
ABSTRACT | FULL TEXT